Middle East and Africa Breast Lesion Localization Methods Market Size, Share, Growth, Trends, and Global Industry Analysis: By Technology, Radio Occult Lesion Localization, Others), Wire Guided localization, Magnetic Tracker, Others), By End User, and Others) and Country Forecast 2020-2031
Middle East and Africa Breast Lesion Localization Methods Market size was valued at US$ 114.2 million in 2024 and is expected to reach US$ 150.3 million by 2031, growing at a significant CAGR of 4.9% from 2025-2031. Breast cancer is characterized by the abnormal multiplication of the breast cells that will form lumps, which may be nonmalignant or malignant. Such abnormal breast cells usually form tumors, which may often be observed on x-ray. Breast cancer occurs commonly in women above 40 years of age and often it can be seen in men also. For the early detection of lumps or lesions, various methods are used. Breast lesion localization methods are used to detect the nonpalatable suspicious breast lesions during the biopsy.
In both industrialised and developing countries, breast cancer is one of the most common diseases affecting women. Breast cancer is the second-leading cause of cancer-related deaths in women throughout the Middle East and Africa, according to the American Cancer Society. The frequency of breast cancer cases has increased significantly throughout the Middle East and Africa. This can be ascribed to a variety of factors, including changing lifestyles, increased use of oral contraceptives, and an increase in the number of women getting aesthetic procedures such as breast augmentation.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Market Size in 2024 |
US$ 114.2 million |
|
Market Size in 2031 |
US$ 150.3 million |
|
By Technology |
|
|
By End User |
|
|
By Country |
|
Download Free Sample Report
The Middle East and Africa Breast lesion localization methods market size was valued at US$ 114.2 million in 2024 and is expected to reach US$ 150.3 million by 2031, growing at a significant CAGR of 4.9% from 2025-2031
The Middle East and Africa Breast Lesion Localization Methods Market key players are: Cianna Medical, Inc. (U.S.) STERYLAB (Italy) Cook Group Inc. (U.S.) SOMATEX Medical Technologies GmbH (Germany) CP Medical, Inc. (Theragenics Corporation) (U.S.) R. Bard, Inc. (U.S.) Argon Medical Devices, Inc. (ACI Medical Devices, Inc.) (U.S.) Faxitron, Inc. (Faxitron Bioptics, LLC) (U.S.) Endomag (U.K.)
| 1. Executive Summary |
| 2. Middle East and Africa Breast Lesion Localization Methods Market Introduction |
| 2.1. Middle East and Africa Breast Lesion Localization Methods Market - Taxonomy |
| 2.2. Middle East and Africa Breast Lesion Localization Methods Market - Definitions |
| 2.2.1.Technology |
| 2.2.2.End User |
| 3. Middle East and Africa Breast Lesion Localization Methods Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Middle East and Africa Breast Lesion Localization Methods Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Middle East and Africa Breast Lesion Localization Methods Market By Technology, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Radio Isotope Localization |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Wire Guided localization |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Magnetic Tracker |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Middle East and Africa Breast Lesion Localization Methods Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Ambulatory Surgical Centers (ASC’s) |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Competition Landscape |
| 7.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 7.2.1.Cianna Medical, Inc. (U.S.) |
| 7.2.2.STERYLAB (Italy) |
| 7.2.3.Cook Group Inc. (U.S.) |
| 7.2.4.SOMATEX Medical Technologies GmbH (Germany) |
| 7.2.5.CP Medical, Inc. (Theragenics Corporation) (U.S.) |
| 7.2.6.R. Bard, Inc. (U.S.) |
| 7.2.7.Argon Medical Devices, Inc. (ACI Medical Devices, Inc.) (U.S.) |
| 7.2.8.Faxitron, Inc. (Faxitron Bioptics, LLC) (U.S.) |
| 7.2.9.Endomag (U.K.) |
| 8. Research Methodology |
| 9. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
